DuPont Decomposition

Why does KOLTEPATIL earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

12.7% = 6.2% × 0.32 × 6.34

Latest: FY2025

Profitability

Net Margin

6.2%

15.2% →6.2%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.32x

0.19x →0.32x

Revenue per ₹ of assets

Leverage

Equity Multiplier

6.34x

4.03x →6.34x

Assets funded by equity vs debt

Trend Analysis

ROE improved by 1.2 pp over 3 years. Driven by net margin declining (15.2% → 6.2%), asset turnover improving (0.19x → 0.32x), leverage rising (4.03x → 6.34x). High financial leverage (equity multiplier > 4x) amplifies returns but also risk.

Historical Decomposition

Last 3 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20230Cr0Cr15.2%0.194.0311.5%
FY20240Cr-0Cr-5.0%0.116.74-3.6%
FY20250Cr0Cr6.2%0.326.3412.7%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for KOLTEPATIL

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.